Study guide

14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV

Key Takeaways Explain This Topic AI

Sensitivity (TP / [TP + FN]) measures true positive rate; high sensitivity tests minimize false negatives (SnNOut) and are optimal for screening high-risk diseases.

Specificity (TN / [TN + FP]) measures true negative rate; high specificity tests minimize false positives (SpPIn) and are used to confirm diagnoses.

Positive Predictive Value (PPV = TP / [TP + FP]) and Negative Predictive Value (NPV = TN / [TN + FN]) depend directly on disease prevalence in the tested population.

Increasing disease prevalence raises PPV and lowers NPV, while sensitivity and specificity remain intrinsic properties of the test independent of prevalence.

Likelihood Ratios (LR+ = Sensitivity / [1 - Specificity], LR- = [1 - Sensitivity] / Specificity) convert pre-test probability to post-test probability using Fagan nomograms, independent of prevalence.

Last updated: July 2026

  • 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV
  • The 2x2 Contingency Matrix & Primary Test Metrics

Evaluating diagnostic tests requires placing clinical test results alongside a gold-standard reference method in a standard 2x2 contingency matrix . The true disease status (Disease Present vs. Disease Absent) is positioned along the columns, and test results (Test Positive vs. Test Negative) are positioned along the rows.

  • Diagnostic Test Result Disease Present (Gold Standard +) Disease Absent (Gold Standard -) Total
  • Test Positive (+) True Positives (TP) False Positives (FP) TP + FP
  • Test Negative (-) False Negatives (FN) True Negatives (TN) FN + TN
  • Total TP + FN FP + TN N
  • Sensitivity (True Positive Rate)

Sensitivity measures the probability that a diagnostic test yields a positive result in a patient who truly has the disease: Sensitivity = TP TP + FN \text{Sensitivity} = \frac{\text{TP}}{\text{TP} + \text{FN}} Sensitivity = TP + FN TP ​

Clinical Mnemonic : SnNOut — A test with high Sn sitivity, when N egative, rules Out the disease. High-sensitivity tests produce very few false negatives, making them ideal for initial screening of serious conditions (e.g., HIV screening with ELISA, D-dimer for pulmonary embolism).

Specificity (True Negative Rate)

Specificity measures the probability that a diagnostic test yields a negative result in a patient who is free of the disease: Specificity = TN TN + FP \text{Specificity} = \frac{\text{TN}}{\text{TN} + \text{FP}} Specificity = TN + FP TN ​

Clinical Mnemonic : SpPIn — A test with high Sp ecificity, when P ositive, rules In the disease. High-specificity tests produce very few false positives, making them ideal for confirmatory testing after a positive screening test (e.g., Western blot/differentiation assay for HIV, lumbar puncture after non-contrast CT for SAH).

Complementary Rates

False Negative Rate (FNR) = 1 − Sensitivity = FN TP + FN = 1 - \text{Sensitivity} = \frac{\text{FN}}{\text{TP} + \text{FN}} = 1 − Sensitivity = TP + FN FN ​

False Positive Rate (FPR) = 1 − Specificity = FP TN + FP = 1 - \text{Specificity} = \frac{\text{FP}}{\text{TN} + \text{FP}} = 1 − Specificity = TN + FP FP ​

Predictive Values & Disease Prevalence

While sensitivity and specificity are intrinsic properties of a diagnostic test (remaining fixed across populations), predictive values measure clinical usefulness in real-world practice and depend heavily on disease prevalence in the population tested.

Positive Predictive Value (PPV)

PPV is the proportion of patients with a positive test result who truly have the disease: PPV = TP TP + FP \text{PPV} = \frac{\text{TP}}{\text{TP} + \text{FP}} PPV = TP + FP TP ​

Negative Predictive Value (NPV)

NPV is the proportion of patients with a negative test result who are truly free of the disease: NPV = TN TN + FN \text{NPV} = \frac{\text{TN}}{\text{TN} + \text{FN}} NPV = TN + FN TN ​

Impact of Disease Prevalence

Increasing Disease Prevalence : As prevalence increases, the absolute number of True Positives increases while False Positives decrease relative to true cases. Consequently, PPV increases while NPV decreases .

Decreasing Disease Prevalence : In a low-prevalence screening population (e.g., screening asymptomatic young adults for rare disorders), PPV drops dramatically (most positive results are false positives), while NPV approaches 100% .

Population Setting Disease Prevalence Sensitivity & Specificity Positive Predictive Value (PPV) Negative Predictive Value (NPV)

  • Tertiary Referral Clinic High Unchanged (Fixed) High Low
  • General Community Screening Low Unchanged (Fixed) Low High
  • Diagnostic Cutoff Adjustments & ROC Curves

When diagnostic tests rely on continuous laboratory variables (e.g., blood glucose, serum troponin, prostate-specific antigen), clinicians must choose a numeric cutoff value to classify results as positive or negative. Shifting this threshold alters the distribution of true positives, false positives, true negatives, and false negatives. Disease Absent (Healthy) Disease Present (Sick)

  • /------------------\ /------------------\
  • / \ / \
  • / \ / \
  • +------------------------+------+------------------------+
  • ^ ^
  • Cutoff B Cutoff A
  • Effects of Shifting Cutoffs

Lowering the Cutoff Value (Moving Cutoff Left toward healthy distribution) :

Captures more true cases → \rightarrow → Increases Sensitivity and True Positives .

Decreases missed cases → \rightarrow → Decreases False Negatives .

Mistakenly classifies more healthy people → \rightarrow → Decreases Specificity and True Negatives .

Increases incorrect positives → \rightarrow → Increases False Positives .

Clinical Indication : Preferred when missing a diagnosis is life-threatening (e.g., cardiac troponin for acute coronary syndrome).

Raising the Cutoff Value (Moving Cutoff Right toward diseased distribution) :

Requires higher threshold → \rightarrow → Increases Specificity and True Negatives .

Decreases false alarms → \rightarrow → Decreases False Positives .

Misses mild cases → \rightarrow → Decreases Sensitivity and True Positives .

Increases missed cases → \rightarrow → Decreases False Negatives .

Clinical Indication : Preferred when false positive diagnoses cause severe harm, unnecessary invasive surgery, or severe psychological distress.

Receiver Operating Characteristic (ROC) Curves

An ROC curve plots Sensitivity ( y y y -axis) against 1 − Specificity 1 - \text{Specificity} 1 − Specificity (False Positive Rate, x x x -axis) for every possible cutoff threshold of a continuous test.

Area Under the Curve (AUC) : Quantifies overall diagnostic accuracy across all cutoffs.

AUC = 1.0 \text{AUC} = 1.0 AUC = 1.0 : Perfect diagnostic test (100% sensitivity and 100% specificity).

AUC = 0.5 \text{AUC} = 0.5 AUC = 0.5 : Useless test (diagonal line of chance, equivalent to a coin flip).

The optimal cutoff point on an ROC curve is typically the point closest to the upper-left corner ( 0 , 1 ) (0, 1) ( 0 , 1 ) , maximizing both sensitivity and specificity.

Likelihood Ratios & Fagan Nomogram

Unlike PPV and NPV, Likelihood Ratios (LRs) combine sensitivity and specificity into single metrics that are independent of disease prevalence . They quantify how much a test result modifies the pre-test probability of disease into a post-test probability .

Formulas

Positive Likelihood Ratio ( L R + LR+ L R + ) : Sensitivity 1 − Specificity = True Positive Rate False Positive Rate \frac{\text{Sensitivity}}{1 - \text{Specificity}} = \frac{\text{True Positive Rate}}{\text{False Positive Rate}} 1 − Specificity Sensitivity ​ = False Positive Rate True Positive Rate ​

L R + > 10 LR+ > 10 L R + > 10 : Generates a large, conclusive increase in disease probability (rules IN disease).

L R + = 5 − 10 LR+ = 5 - 10 L R + = 5 − 10 : Moderate increase in post-test probability.

Negative Likelihood Ratio ( L R − LR- L R − ) : 1 − Sensitivity Specificity = False Negative Rate True Negative Rate \frac{1 - \text{Sensitivity}}{\text{Specificity}} = \frac{\text{False Negative Rate}}{\text{True Negative Rate}} Specificity 1 − Sensitivity ​ = True Negative Rate False Negative Rate ​

L R − < 0.1 LR- < 0.1 L R − < 0.1 : Generates a large, conclusive decrease in disease probability (rules OUT disease).

L R − = 0.1 − 0.2 LR- = 0.1 - 0.2 L R − = 0.1 − 0.2 : Moderate decrease in post-test probability.

Application via Odds Pre-test Odds = Pre-test Probability 1 − Pre-test Probability \text{Pre-test Odds} = \frac{\text{Pre-test Probability}}{1 - \text{Pre-test Probability}} Pre-test Odds = 1 − Pre-test Probability Pre-test Probability ​ Post-test Odds = Pre-test Odds × Likelihood Ratio \text{Post-test Odds} = \text{Pre-test Odds} \times \text{Likelihood Ratio} Post-test Odds = Pre-test Odds × Likelihood Ratio Post-test Probability = Post-test Odds 1 + Post-test Odds \text{Post-test Probability} = \frac{\text{Post-test Odds}}{1 + \text{Post-test Odds}} Post-test Probability = 1 + Post-test Odds Post-test Odds ​

Diagnostic & Screening Algorithm

When selecting and interpreting diagnostic studies on Step 2 CK:

What is the goal of testing?

Initial Screening / Exclude Disease → \rightarrow → Choose test with High Sensitivity (low false negatives).

Confirm Suspected Diagnosis → \rightarrow → Choose test with High Specificity (low false positives).

How does moving from a community setting to a specialist clinic affect metrics?

Disease prevalence increases → \rightarrow → PPV increases , NPV decreases , Sensitivity & Specificity remain constant .

What happens if the diagnostic threshold cutoff is reduced?

Cutoff lowered → \rightarrow → Sensitivity ↑ \uparrow ↑ , False Positives ↑ \uparrow ↑ , Specificity ↓ \downarrow ↓ , False Negatives ↓ \downarrow ↓ .